Here, we generated germline mutations in the mouse Mpl gene allowing definitive insights into the roles of specific domains and intracellular tyrosine residues in vivo in the context of endogenous control of receptor expression, both in healthy hematopoiesis and MPN. This evidence concerns the gene MPL and myeloproliferative disorder.